Is HTFL or SOPH more profitable?

Heartflow has a net margin of -55.82% compared to SOPHiA GENETICS's net margin of -93.86%. Heartflow's return on equity of -23.52% beat SOPHiA GENETICS's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% SOPHiA GENETICS -93.86% -132.47% -45.97%

Does the media favor HTFL or SOPH?

In the previous week, Heartflow had 16 more articles in the media than SOPHiA GENETICS. MarketBeat recorded 19 mentions for Heartflow and 3 mentions for SOPHiA GENETICS. Heartflow's average media sentiment score of 0.64 beat SOPHiA GENETICS's score of 0.34 indicating that Heartflow is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 9 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SOPHiA GENETICS 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to SDGR or SOPH?

In the previous week, Schrodinger and Schrodinger both had 3 articles in the media. Schrodinger's average media sentiment score of 1.03 beat SOPHiA GENETICS's score of 0.34 indicating that Schrodinger is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SOPHiA GENETICS 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to TDOC or SOPH?

In the previous week, Teladoc Health had 14 more articles in the media than SOPHiA GENETICS. MarketBeat recorded 17 mentions for Teladoc Health and 3 mentions for SOPHiA GENETICS. Teladoc Health's average media sentiment score of 0.61 beat SOPHiA GENETICS's score of 0.34 indicating that Teladoc Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teladoc Health 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SOPHiA GENETICS 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, GDRX or SOPH?

GoodRx has higher revenue and earnings than SOPHiA GENETICS. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio GoodRx $796.85M 1.48 $30.44M $0.04 86.25 SOPHiA GENETICS $77.27M 9.39 -$79M -$1.15 N/A

Is GDRX or SOPH more profitable?

GoodRx has a net margin of 2.07% compared to SOPHiA GENETICS's net margin of -93.86%. GoodRx's return on equity of 7.22% beat SOPHiA GENETICS's return on equity. Company Net Margins Return on Equity Return on Assets GoodRx 2.07% 7.22% 2.53% SOPHiA GENETICS -93.86% -132.47% -45.97%

Does the media prefer GDRX or SOPH?

In the previous week, GoodRx had 5 more articles in the media than SOPHiA GENETICS. MarketBeat recorded 8 mentions for GoodRx and 3 mentions for SOPHiA GENETICS. GoodRx's average media sentiment score of 0.37 beat SOPHiA GENETICS's score of 0.34 indicating that GoodRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GoodRx 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SOPHiA GENETICS 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is SOPH or CERT more profitable?

Certara has a net margin of -16.75% compared to SOPHiA GENETICS's net margin of -93.86%. Certara's return on equity of 3.86% beat SOPHiA GENETICS's return on equity. Company Net Margins Return on Equity Return on Assets SOPHiA GENETICS -93.86% -132.47% -45.97% Certara -16.75% 3.86% 2.65%

Does the media favor SOPH or CERT?

In the previous week, SOPHiA GENETICS and SOPHiA GENETICS both had 3 articles in the media. Certara's average media sentiment score of 1.55 beat SOPHiA GENETICS's score of 0.34 indicating that Certara is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SOPHiA GENETICS 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Certara 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

SOPHiA GENETICS (SOPH) Competitors

$8.65 +0.32 (+3.84%)

As of 08/21/2026 04:00 PM Eastern

Compare

SOPH vs. HTFL, SDGR, TDOC, GDRX, and CERT

Should you buy SOPHiA GENETICS stock or one of its competitors? SOPHiA GENETICS's main competitors and comparable companies include Heartflow (HTFL), Schrodinger (SDGR), Teladoc Health (TDOC), GoodRx (GDRX), and Certara (CERT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does SOPHiA GENETICS compare to Heartflow?

Heartflow (NASDAQ:HTFL) and SOPHiA GENETICS (NASDAQ:SOPH) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

In the previous week, Heartflow had 16 more articles in the media than SOPHiA GENETICS. MarketBeat recorded 19 mentions for Heartflow and 3 mentions for SOPHiA GENETICS. Heartflow's average media sentiment score of 0.64 beat SOPHiA GENETICS's score of 0.34 indicating that Heartflow is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heartflow	9 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
SOPHiA GENETICS	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

31.6% of SOPHiA GENETICS shares are held by institutional investors. 7.7% of Heartflow shares are held by insiders. Comparatively, 4.9% of SOPHiA GENETICS shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

SOPHiA GENETICS has lower revenue, but higher earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than SOPHiA GENETICS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	24.57	-$116.79M	-$1.83	N/A
SOPHiA GENETICS	$77.27M	9.39	-$79M	-$1.15	N/A

Heartflow currently has a consensus price target of $43.43, suggesting a potential downside of 12.71%. SOPHiA GENETICS has a consensus price target of $10.00, suggesting a potential upside of 15.61%. Given SOPHiA GENETICS's higher possible upside, analysts plainly believe SOPHiA GENETICS is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
SOPHiA GENETICS	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Heartflow has a net margin of -55.82% compared to SOPHiA GENETICS's net margin of -93.86%. Heartflow's return on equity of -23.52% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%

Summary

Heartflow beats SOPHiA GENETICS on 11 of the 16 factors compared between the two stocks.

How does SOPHiA GENETICS compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and SOPHiA GENETICS (NASDAQ:SOPH) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.

SOPHiA GENETICS has lower revenue, but higher earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than SOPHiA GENETICS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	5.69	-$103.26M	-$0.74	N/A
SOPHiA GENETICS	$77.27M	9.39	-$79M	-$1.15	N/A

Schrodinger has a net margin of -20.98% compared to SOPHiA GENETICS's net margin of -93.86%. Schrodinger's return on equity of -16.37% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%

Schrodinger has a beta of 1.63, indicating that its stock price is 63% more volatile than the broader market. Comparatively, SOPHiA GENETICS has a beta of 0.96, indicating that its stock price is 4% less volatile than the broader market.

In the previous week, Schrodinger and Schrodinger both had 3 articles in the media. Schrodinger's average media sentiment score of 1.03 beat SOPHiA GENETICS's score of 0.34 indicating that Schrodinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SOPHiA GENETICS	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Schrodinger presently has a consensus price target of $20.50, suggesting a potential upside of 4.01%. SOPHiA GENETICS has a consensus price target of $10.00, suggesting a potential upside of 15.61%. Given SOPHiA GENETICS's stronger consensus rating and higher probable upside, analysts clearly believe SOPHiA GENETICS is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
SOPHiA GENETICS	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

79.1% of Schrodinger shares are owned by institutional investors. Comparatively, 31.6% of SOPHiA GENETICS shares are owned by institutional investors. 10.1% of Schrodinger shares are owned by company insiders. Comparatively, 4.9% of SOPHiA GENETICS shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Schrodinger beats SOPHiA GENETICS on 9 of the 14 factors compared between the two stocks.

How does SOPHiA GENETICS compare to Teladoc Health?

Teladoc Health (NYSE:TDOC) and SOPHiA GENETICS (NASDAQ:SOPH) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

Teladoc Health has a net margin of -7.13% compared to SOPHiA GENETICS's net margin of -93.86%. Teladoc Health's return on equity of -12.15% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teladoc Health	-7.13%	-12.15%	-5.83%
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%

SOPHiA GENETICS has lower revenue, but higher earnings than Teladoc Health. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teladoc Health	$2.53B	0.46	-$200.32M	-$0.99	N/A
SOPHiA GENETICS	$77.27M	9.39	-$79M	-$1.15	N/A

Teladoc Health has a beta of 2.12, indicating that its share price is 112% more volatile than the broader market. Comparatively, SOPHiA GENETICS has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market.

Teladoc Health currently has a consensus target price of $7.54, suggesting a potential upside of 17.56%. SOPHiA GENETICS has a consensus target price of $10.00, suggesting a potential upside of 15.61%. Given Teladoc Health's higher probable upside, equities analysts clearly believe Teladoc Health is more favorable than SOPHiA GENETICS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teladoc Health	1 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.25
SOPHiA GENETICS	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Teladoc Health had 14 more articles in the media than SOPHiA GENETICS. MarketBeat recorded 17 mentions for Teladoc Health and 3 mentions for SOPHiA GENETICS. Teladoc Health's average media sentiment score of 0.61 beat SOPHiA GENETICS's score of 0.34 indicating that Teladoc Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teladoc Health	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SOPHiA GENETICS	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 31.6% of SOPHiA GENETICS shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by insiders. Comparatively, 4.9% of SOPHiA GENETICS shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Teladoc Health beats SOPHiA GENETICS on 12 of the 16 factors compared between the two stocks.

How does SOPHiA GENETICS compare to GoodRx?

GoodRx (NASDAQ:GDRX) and SOPHiA GENETICS (NASDAQ:SOPH) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations.

GoodRx presently has a consensus price target of $4.23, suggesting a potential upside of 22.53%. SOPHiA GENETICS has a consensus price target of $10.00, suggesting a potential upside of 15.61%. Given GoodRx's higher possible upside, equities research analysts plainly believe GoodRx is more favorable than SOPHiA GENETICS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08
SOPHiA GENETICS	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

GoodRx has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market. Comparatively, SOPHiA GENETICS has a beta of 0.96, indicating that its share price is 4% less volatile than the broader market.

GoodRx has a net margin of 2.07% compared to SOPHiA GENETICS's net margin of -93.86%. GoodRx's return on equity of 7.22% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	2.07%	7.22%	2.53%
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%

GoodRx has higher revenue and earnings than SOPHiA GENETICS. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$796.85M	1.48	$30.44M	$0.04	86.25
SOPHiA GENETICS	$77.27M	9.39	-$79M	-$1.15	N/A

In the previous week, GoodRx had 5 more articles in the media than SOPHiA GENETICS. MarketBeat recorded 8 mentions for GoodRx and 3 mentions for SOPHiA GENETICS. GoodRx's average media sentiment score of 0.37 beat SOPHiA GENETICS's score of 0.34 indicating that GoodRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
SOPHiA GENETICS	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

63.8% of GoodRx shares are owned by institutional investors. Comparatively, 31.6% of SOPHiA GENETICS shares are owned by institutional investors. 5.9% of GoodRx shares are owned by company insiders. Comparatively, 4.9% of SOPHiA GENETICS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

GoodRx beats SOPHiA GENETICS on 14 of the 16 factors compared between the two stocks.

How does SOPHiA GENETICS compare to Certara?

SOPHiA GENETICS (NASDAQ:SOPH) and Certara (NASDAQ:CERT) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, valuation, dividends, risk and institutional ownership.

SOPHiA GENETICS has a beta of 0.96, meaning that its share price is 4% less volatile than the broader market. Comparatively, Certara has a beta of 1.44, meaning that its share price is 44% more volatile than the broader market.

Certara has higher revenue and earnings than SOPHiA GENETICS. Certara is trading at a lower price-to-earnings ratio than SOPHiA GENETICS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SOPHiA GENETICS	$77.27M	9.39	-$79M	-$1.15	N/A
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A

In the previous week, SOPHiA GENETICS and SOPHiA GENETICS both had 3 articles in the media. Certara's average media sentiment score of 1.55 beat SOPHiA GENETICS's score of 0.34 indicating that Certara is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SOPHiA GENETICS	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Certara	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

SOPHiA GENETICS presently has a consensus target price of $10.00, suggesting a potential upside of 15.61%. Certara has a consensus target price of $8.28, suggesting a potential downside of 1.81%. Given SOPHiA GENETICS's higher possible upside, equities analysts plainly believe SOPHiA GENETICS is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SOPHiA GENETICS	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

31.6% of SOPHiA GENETICS shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 4.9% of SOPHiA GENETICS shares are owned by insiders. Comparatively, 1.1% of Certara shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Certara has a net margin of -16.75% compared to SOPHiA GENETICS's net margin of -93.86%. Certara's return on equity of 3.86% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%
Certara	-16.75%	3.86%	2.65%

Summary

Certara beats SOPHiA GENETICS on 12 of the 16 factors compared between the two stocks.

Get SOPHiA GENETICS News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SOPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SOPH vs. The Competition

Export

Metric	SOPHiA GENETICS	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$725.69M	$1.72B	$7.37B	$12.85B
Dividend Yield	N/A	4.69%	2.53%	11.08%
P/E Ratio	-7.52	21.09	272.60	24.25
Price / Sales	9.39	75.95	618.96	99.78
Price / Cash	N/A	31.69	78.62	53.99
Price / Book	8.74	6.98	13.05	6.20
Net Income	-$79M	-$18.66M	$3.47B	$348.59M
7 Day Performance	15.33%	0.54%	2.09%	0.08%
1 Month Performance	42.98%	12.80%	6.64%	3.88%
1 Year Performance	139.61%	-17.12%	25.02%	16.98%

SOPHiA GENETICS Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SOPH SOPHiA GENETICS	2.5593 of 5 stars	$8.65 +3.8%	$10.00 +15.6%	+139.6%	$725.69M	$77.27M	N/A	520
HTFL Heartflow	1.5447 of 5 stars	$29.54 +0.6%	$36.57 +23.8%	+70.6%	$2.53B	$176.03M	N/A	699	News Coverage Insider Trade
SDGR Schrodinger	1.0472 of 5 stars	$18.65 -0.6%	$20.25 +8.6%	-3.0%	$1.39B	$259.04M	N/A	790
TDOC Teladoc Health	3.4212 of 5 stars	$6.80 -3.9%	$7.54 +10.8%	-16.5%	$1.29B	$2.49B	N/A	5,600	Trending News Analyst Forecast Analyst Revision
GDRX GoodRx	4.3351 of 5 stars	$3.80 +3.8%	$4.16 +9.4%	-24.3%	$1.25B	$796.85M	95.02	950	News Coverage Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SOPH) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SOPHiA GENETICS (SOPH) Competitors

SOPH vs. HTFL, SDGR, TDOC, GDRX, and CERT

How does SOPHiA GENETICS compare to Heartflow?

Summary

How does SOPHiA GENETICS compare to Schrodinger?

Summary

How does SOPHiA GENETICS compare to Teladoc Health?

Summary

How does SOPHiA GENETICS compare to GoodRx?

Summary

How does SOPHiA GENETICS compare to Certara?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SOPH vs. The Competition

SOPHiA GENETICS Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SOPHiA GENETICS (SOPH) Competitors

SOPH vs. HTFL, SDGR, TDOC, GDRX, and CERT

How does SOPHiA GENETICS compare to Heartflow?

Does the media favor HTFL or SOPH?

Do institutionals & insiders hold more shares of HTFL or SOPH?

Which has preferable earnings & valuation, HTFL or SOPH?

Do analysts recommend HTFL or SOPH?

Is HTFL or SOPH more profitable?

Summary

How does SOPHiA GENETICS compare to Schrodinger?

Which has better valuation & earnings, SDGR or SOPH?

Is SDGR or SOPH more profitable?

Which has more volatility and risk, SDGR or SOPH?

Does the media refer more to SDGR or SOPH?

Do analysts prefer SDGR or SOPH?

Do institutionals and insiders hold more shares of SDGR or SOPH?

Summary

How does SOPHiA GENETICS compare to Teladoc Health?

Is TDOC or SOPH more profitable?

Which has higher earnings and valuation, TDOC or SOPH?

Which has more risk & volatility, TDOC or SOPH?

Do analysts prefer TDOC or SOPH?

Does the media refer more to TDOC or SOPH?

Do institutionals & insiders hold more shares of TDOC or SOPH?

Summary

How does SOPHiA GENETICS compare to GoodRx?

Do analysts prefer GDRX or SOPH?

Which has more volatility & risk, GDRX or SOPH?

Is GDRX or SOPH more profitable?

Which has preferable valuation and earnings, GDRX or SOPH?

Does the media prefer GDRX or SOPH?

Do insiders & institutionals hold more shares of GDRX or SOPH?

Summary

How does SOPHiA GENETICS compare to Certara?

Which has more volatility and risk, SOPH or CERT?

Which has higher earnings & valuation, SOPH or CERT?

Does the media favor SOPH or CERT?

Do analysts prefer SOPH or CERT?

Do insiders and institutionals have more ownership in SOPH or CERT?

Is SOPH or CERT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SOPH vs. The Competition

SOPHiA GENETICS Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools